Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
23,267,064
-
Total 13F shares
-
1,345,552
-
Share change
-
+338,576
-
Total reported value
-
$20,048,209
-
Price per share
-
$14.90
-
Number of holders
-
24
-
Value change
-
+$6,295,667
-
Number of buys
-
11
-
Number of sells
-
10
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q4 2016
As of 31 Dec 2016,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,345,552 shares.
The largest 10 holders included
Capital World Investors, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., and Paloma Partners Management Co.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.